Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118379962 | 11837996 | 2 | F | 20151123 | 20160624 | 20151215 | 20160706 | EXP | PL-PFIZER INC-2015443213 | PFIZER | 65.00 | YR | M | Y | 62.00000 | KG | 20160706 | MD | PL | PL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118379962 | 11837996 | 1 | SS | PF-06439535 | INVESTIGATIONAL PRODUCT | 1 | Intravenous (not otherwise specified) | 930 MG, EVERY 3 WEEKS | 930 | MG | 0 | 930 | MG | SOLUTION FOR INFUSION | Q3W | ||||
118379962 | 11837996 | 2 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 881.13 MG, EVERY 3 WEEKS | 881 | MG | 76517 | 881.13 | MG | Q3W | |||||
118379962 | 11837996 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 348 MG, EVERY 3 WEEKS | 348 | MG | 76131 | 348 | MG | Q3W | |||||
118379962 | 11837996 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 20 MG, 2X/DAY | 0 | 20 | MG | BID | |||||||
118379962 | 11837996 | 5 | C | CLEMASTIN | CLEMASTINE | 1 | Intravenous (not otherwise specified) | 2 MG, 1X/DAY, ONCE | 0 | 2 | MG | QD | |||||||
118379962 | 11837996 | 6 | C | RANIGAST | 2 | Intravenous (not otherwise specified) | 50 MG, 1X/DAY, ONCE | 0 | 50 | MG | QD | ||||||||
118379962 | 11837996 | 7 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 16 MG, 1X/DAY, ONCE | 0 | 16 | MG | QD | |||||||
118379962 | 11837996 | 8 | C | NATRIUM CHLORATUM 0.9% | 2 | Intravenous (not otherwise specified) | 500 ML, 1X/DAY | 0 | 500 | ML | QD | ||||||||
118379962 | 11837996 | 9 | C | KETONAL | KETOPROFEN | 1 | Oral | 0.05 G, 1X/DAY | 0 | .05 | G | QD | |||||||
118379962 | 11837996 | 10 | C | BUSCOLIZYN | 2 | Intravenous (not otherwise specified) | 20 MG, 1X/DAY | 20 | MG | 0 | 20 | MG | QD | ||||||
118379962 | 11837996 | 11 | C | IPP /00661201/ | 2 | Oral | 20 MG, 1X/DAY | 20 | MG | 0 | 20 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118379962 | 11837996 | 1 | Non-small cell lung cancer |
118379962 | 11837996 | 2 | Non-small cell lung cancer |
118379962 | 11837996 | 3 | Non-small cell lung cancer |
118379962 | 11837996 | 4 | Premedication |
118379962 | 11837996 | 5 | Premedication |
118379962 | 11837996 | 6 | Premedication |
118379962 | 11837996 | 7 | Antiemetic supportive care |
118379962 | 11837996 | 11 | Premedication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118379962 | 11837996 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118379962 | 11837996 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118379962 | 11837996 | 1 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 2 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 3 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 4 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 5 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 6 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 7 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 8 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 9 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 10 | 20151119 | 20151119 | 0 | |
118379962 | 11837996 | 11 | 20151119 | 20151119 | 0 |